🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesHas anyone dealt with my dad had a heart attack and now i am terrified - will glp-1 help??

Has anyone dealt with my dad had a heart attack and now i am terrified - will glp-1 help??

chris_chi24 Sat, Jan 10, 2026 at 1:08 PM 18 replies 1,212 viewsPage 1 of 4
chris_chi24
Member
389
1,678
Sep 2024
Chicago, IL
Jan 10, 2026 at 1:08 PM#1

My reason for being on this is cardiovascular rather than cosmetic, which puts me in a small minority in most of these threads.

What I am after is how much of the SELECT benefit is plausibly independent of the weight loss, and whether that distinction changes anything practical.

I have searched first, so if this is covered somewhere point me at it and I will read it.

31 9nick_newbie, DadBodDave, AmyNC_wife and 28 others
Reply Quote Save Share Report
Dr.ObesityLA
VIP Member
3,567
19,876
Dec 2023
Los Angeles, CA
Jan 10, 2026 at 1:25 PM#2
chris_chi24 said:
My reason for being on this is cardiovascular rather than cosmetic, which puts me in a small minority in most of these threads.

Lp(a) and cardiovascular risk: a nuance that matters. Unlike most lipid markers, Lp(a) is 90%+ genetically determined and doesn't really change with weight loss or GLP-1 therapy.

My Lp(a) has remained at 62 nmol/L across all time points. If yours is elevated (>50 nmol/L), you need additional risk mitigation strategies regardless of your GLP-1 response. Don't assume your medication is covering all cardiovascular risk factors.

32 10KarenAZ_mom, zoe_NC, Dr.ObesityLA and 29 others
Reply Quote Save Share Report
ZaraB_AL
Member
456
1,678
Jan 2025
Alabama
Jan 10, 2026 at 1:42 PM#3
Dr.ObesityLA said:
Lp(a) and cardiovascular risk: a nuance that matters.

Anti-inflammatory mechanisms of GLP-1 agonists and cardiovascular risk: beyond weight loss, GLP-1R activation directly suppresses NF-κB signaling, reduces NLRP3 inflammasome activation, and decreases monocyte/macrophage adhesion to endothelium[1].

Clinical correlates: hsCRP reduction of 30-60% (consistently seen across trials), reduced carotid intima-media thickness, and decreased coronary plaque inflammation on PET imaging.

These anti-inflammatory effects likely contribute to the cardiovascular benefit seen in SELECT — and may explain benefits beyond what weight loss alone would predict.

References:
[1] Hogan AE, et al. Diabetologia. 2014;57(4):781-784.
33 11TirzTom, TrialTracker_MD, JennaRN and 30 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
zoe_NC
Member
278
1,234
Nov 2024
Charlotte, NC
Jan 10, 2026 at 1:59 PM#4
chris_chi24 said:
My reason for being on this is cardiovascular rather than cosmetic, which puts me in a small minority in most of these threads.

Can confirm. Same sequence, different timescale. Posting only so the count is not one.

Last edited: Jan 10, 2026 at 2:59 PM
34 12NicoleRaleigh, james_edin, FranDenver and 31 others
Reply Quote Save Share Report
Dr.NateNeph
VIP Member
2,987
16,234
Dec 2023
Houston, TX
Jan 10, 2026 at 3:30 PM#5

From the other side of the consultation, briefly.

chris_chi24 said:
...we're creating a generation dependent on cardiovascular risk...

I understand the concern, but consider this analogy: are we "creating a generation dependent on" blood pressure medication? Cholesterol medication? Thyroid medication?

Obesity is a chronic disease with biological drivers. Treating it with medication is no different from treating any other chronic condition. The "dependency" framing implies weakness or moral failure — neither of which is accurate.

If ongoing medication is what keeps someone healthy, that's successful treatment, not dependency.

Last edited: Jan 10, 2026 at 5:30 PM
35 13RickReta_CO, PharmHunterJen, TomTeleRx and 32 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register